#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ventricular tachycardia Chondrosarcoma metastatic Skin angiosarcoma X-linked lymphoproliferative syndrome Thrombocytosis Oesophageal adenocarcinoma Asthma Medulloblastoma recurrent Noonan syndrome Chronic lymphocytic leukaemia Congenital absence of bile ducts Antiphospholipid syndrome Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Erythema Glycogen storage disease type I More trials…

    Learn about Rare Diseases

    Noonan syndrome – Trials in Disease Angiosarcoma metastatic – Life with Disease Ewing’s sarcoma Congenital hypotransferrinaemia – Trials in Disease Alexander disease Pituitary-dependent Cushing’s syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Angiosarcoma non-metastatic Mantle cell lymphoma refractory – Basic Information Sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ifinatamab Deruxtecan LY4170156 Clemastine Fumarate Carbamazepine Cx-037231 Mr0005 Envudeucitinib Lactose Aup1602-C Fentanyl Rotigotine Calcium Folinate Pentahydrate Citric Acid Levocarnitine Citicoline Sodium Asp1570 Tinlarebant Crinecerfont Tertomotide Olea Europaea Pollen Extract More therapies…

    Learn about Your Condition

    Anaemia Dysmenorrhoea Wiskott-Aldrich syndrome Liver transplant rejection Follicular lymphoma stage II Small fibre neuropathy Hepatobiliary cancer Meniscus operation Anal squamous cell carcinoma Colon cancer Endocrine ophthalmopathy Oesophageal cancer metastatic Plasma cell myeloma Retinal vein occlusion Muscular dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Anakinra and Prednisone for Children with Colchicine-Resistant Recurrent Pericarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pericarditis
    Investigated Drugs:
    • Anakinra
    • Prednisone
    Italy

  • Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Misoprostol
    Sweden

  • Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin’s Lymphoma and Chronic Graft Versus Host Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Graft versus host disease
    • B-cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Nivolumab
    Belgium France Germany Greece Italy Poland +2

  • Study on Zanubrutinib, Tislelizumab, and Sonrotoclax for Patients with Richter Transformation (a type of lymphoma)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    • Tislelizumab
    Austria Denmark Germany

  • Study on the Effectiveness of Botensilimab and Balstilimab for Patients with Various dMMR and pMMR Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Balstilimab
    • Botensilimab
    The Netherlands

  • Study on the Benefits of Amyloid PET Imaging with Florbetaben (18F) and Flutemetamol (18F) for Patients with Various Types of Dementia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Germany
Previous Page
1 … 540 541 542 543 544 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!